RCG
PTX

Ruggie Capital Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Ruggie Capital Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12,500
Closed -$5K – 521
2018
Q4 		$5K Buy
+12,500
New +$7.77K ﹤0.01% 383

Ruggie Capital Group's PTX Position: Q1 2019 in Review

Ruggie Capital Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 12,500 shares — an estimated $5K sold.

Ruggie Capital Group first reported a position in PTX in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Ruggie Capital Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 12,500 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $5K.
  • Ruggie Capital Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2018 and held it in 1 quarter.
  • Ruggie Capital Group's Pernix Therapeutics Holdings, Inc. position peaked at $5K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Ruggie Capital Group's 13F filing for Q1 2019, filed 24 Apr 2019.